SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000950162-10-000196
Filing Date
2010-06-28
Accepted
2010-06-28 16:18:44
Documents
1

Document Format Files

Seq Description Document Type Size
1 SIGMA TAU AMERICA-SOLIGENIX 13D/A NO. 2 sigmaamersol13dano2_061810.htm SC 13D/A 263919
  Complete submission text file 0000950162-10-000196.txt   266127
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Subject) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-39976 | Film No.: 10920240
SIC: 2834 Pharmaceutical Preparations

Mailing Address 19-21, BOULEVARD DU PRINCE HENRI L-1724 LUXEMBOURG N4 00000
Business Address 19-21, BOULEVARD DU PRINCE HENRI L-1724 LUXEMBOURG N4 00000 1-800-447-0169
Sigma-Tau America S.A. (Filed by) CIK: 0001385930 (see all company filings)

IRS No.: 000000000 | State of Incorp.: N4 | Fiscal Year End: 1231
Type: SC 13D/A